1301 - 1350 of 7939 Results
Title
Year
-
OPENTitle: Split‐Belt Treadmill Training to Improve Gait Adaptation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29238Best OA location URL: https://doi.org/10.1002/mds.29238Citation Count: 8
- A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease—Identifying Those at the Greatest Risk2022OPENTitle: A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease—Identifying Those at the Greatest RiskJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 20Start Page: 12211End Page: 12211Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232012211Best OA location URL: https://www.mdpi.com/1422-0067/23/20/12211/pdf?version=1665659389Citation Count: 7
- Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment2022RESTRICTEDTitle: Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatmentJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-22179-zBest OA location URL: https://www.nature.com/articles/s41598-022-22179-z.pdfCitation Count: 17
-
OPENTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Citation Count: 4
-
OPENTitle: Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 94End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.008Citation Count: 7
-
OPENTitle: Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's CrampJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 123End Page: 132Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29237Citation Count: 3
-
OPENTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 1
-
RESTRICTEDTitle: Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?Journal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00317-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-022-00317-xCitation Count: 4
- Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment2022OPENTitle: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairmentJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 2Issue #: 10Start Page: 923End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833817Citation Count: 25
- Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis2022OPENTitle: Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysisJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 12Start Page: 1469End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-022-02547-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017092Citation Count: 5
-
OPENTitle: Targeting the inflammasome in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.957705Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.957705/pdfCitation Count: 10
-
OPENTitle: Interfacility Transfers for Seizure-Related Emergencies in the United StatesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757868Citation Count: 4
- Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders2022OPENTitle: Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative DisordersJournal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 14Issue #: 42Start Page: 47445End Page: 47460Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acsami.2c14220Best OA location URL: https://doi.org/10.1021/acsami.2c14220Citation Count: 14
- The interplay between structural and functional connectivity in early stage Parkinson's disease patients2022RESTRICTEDTitle: The interplay between structural and functional connectivity in early stage Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 442Issue #:Start Page: 120452End Page: 120452Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120452Citation Count: 7
-
OPENTitle: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma BiomarkersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 11Start Page: 1155End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552044Citation Count: 19
-
OPENTitle: Fecal microbiome alterations in treatment-naive de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00395-8Best OA location URL: https://www.nature.com/articles/s41531-022-00395-8.pdfCitation Count: 16
- The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study2022OPENTitle: The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter studyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1012287Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1012287/pdfCitation Count: 15
- Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 42022RESTRICTEDTitle: Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Journal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 1Start Page: 307End Page: 317Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12797Best OA location URL: https://escholarship.org/content/qt7br8n7s3/qt7br8n7s3.pdf?t=rxcrmfCitation Count: 35
-
OPENTitle: Gender Differences in the Prevalence of Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 86End Page: 93Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13584Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13584Citation Count: 19
-
OPENTitle: Deficiency of the frontotemporal dementia gene GRN results in gangliosidosisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-33500-9Best OA location URL: https://www.nature.com/articles/s41467-022-33500-9.pdfCitation Count: 49
- Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors2022OPENTitle: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 10Start Page: e2235068End Page: e2235068Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdfCitation Count: 30
- Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology2022OPENTitle: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00397-6Best OA location URL: https://www.nature.com/articles/s41531-022-00397-6.pdfCitation Count: 24
-
OPENTitle: neuromaps: structural and functional interpretation of brain mapsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 11Start Page: 1472End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-022-01625-wBest OA location URL: https://www.nature.com/articles/s41592-022-01625-w.pdfCitation Count: 164
- Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants2022OPENTitle: Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 12Start Page: 102565End Page: 102565Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102565Best OA location URL: http://www.jbc.org/article/S0021925822010092/pdfCitation Count: 3
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 4
- Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world Study2022OPENTitle: Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world StudyJournal Name: JMIR Formative ResearchPublisher: JMIR Publications Inc.Vol: 6Issue #: 11Start Page: e40765End Page: e40765Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/40765Best OA location URL: https://jmir.org/api/download?alt_name=formative_v6i11e40765_app1.pdf&filename=cda272c3b0860a3c3018580d7ddb36f6.pdfCitation Count: 8
- Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI2022RESTRICTEDTitle: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288Citation Count: 7
- Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study2022RESTRICTEDTitle: Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort StudyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201468Citation Count: 7
- Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicine2022RESTRICTEDTitle: Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicineJournal Name: Frontiers in Molecular MedicinePublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmmed.2022.933383Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmmed.2022.933383/pdfCitation Count: 0
- Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study2022OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 19
-
RESTRICTEDTitle: Progressive Supranuclear Palsy Syndrome Associated With a Novel TauopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: 1094End Page: 1098Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485Citation Count: 7
-
OPENTitle: 147th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: S29Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26484Citation Count: 22
-
OPENTitle: 33RD International Symposium on the Autonomic Nervous SystemJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 5Start Page: 313End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00892-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00892-z.pdfCitation Count: 1
-
OPENTitle: Atypical antipsychotic use and mortality risk in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 103Issue #:Start Page: 17End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013Best OA location URL: http://manuscript.elsevier.com/S1353802022002693/pdf/S1353802022002693.pdfCitation Count: 5
-
RESTRICTEDTitle: Delivery of RNA Therapeutics: The Great Endosomal Escape!Journal Name: Nucleic Acid TherapeuticsPublisher: Mary Ann Liebert IncVol: 32Issue #: 5Start Page: 361End Page: 368Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/nat.2022.0004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595607Citation Count: 44
-
RESTRICTEDTitle: Diagnosis and Medical Management of Parkinson DiseaseJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1281End Page: 1300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001152Citation Count: 3
- Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies2022RESTRICTEDTitle: Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy BodiesJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1314End Page: 1332Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001151Citation Count: 5
-
OPENTitle: ECTRIMS 2022 – PosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 3_supplStart Page: 130End Page: 691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585221123687Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdfCitation Count: 17
-
RESTRICTEDTitle: Emerging therapeutic developments in neurodegenerative diseases: A clinical investigationJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 27Issue #: 10Start Page: 103305End Page: 103305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.drudis.2022.06.005Citation Count: 11
- Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker2022RESTRICTEDTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 21
- Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study2022OPENTitle: Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 14Issue #:Start Page: 1217End Page: 1227Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s381289Best OA location URL: https://www.dovepress.com/getfile.php?fileID=84998Citation Count: 5
- Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease2022OPENTitle: Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s diseaseJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 36End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.clinph.2022.07.489Best OA location URL: https://doi.org/10.1016/j.clinph.2022.07.489Citation Count: 0
-
RESTRICTEDTitle: Issue OverviewJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0Citation Count: 0
-
RESTRICTEDTitle: Mechanisms of NLRP3 activation and pathology during neurodegenerationJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 151Issue #:Start Page: 106273End Page: 106273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2022.106273Citation Count: 10
-
RESTRICTEDTitle: Neurodegenerative Cerebellar AtaxiaJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1409End Page: 1434Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001180Citation Count: 6
- Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina2022OPENTitle: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrinaJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 1Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jex2.59Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jex2.59Citation Count: 67
-
RESTRICTEDTitle: Prodromal α-SynucleinopathiesJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 5Start Page: 1268End Page: 1280Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/con.0000000000001153Citation Count: 0
- Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis2022RESTRICTEDTitle: Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysisJournal Name: CytokinePublisher: Elsevier BVVol: 158Issue #:Start Page: 156006End Page: 156006Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cyto.2022.156006Best OA location URL: https://doi.org/10.1016/j.cyto.2022.156006Citation Count: 25
-
RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 0
- [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease2022OPENTitle: [18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 19Start Page: 3081End Page: 3081Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11193081Best OA location URL: https://www.mdpi.com/2073-4409/11/19/3081/pdf?version=1664531627Citation Count: 5